FDA Issues Warning Over Eli Lilly Diabetes Drug Byetta

Law360, New York (November 3, 2009, 2:17 PM EST) -- The U.S. Food and Drug Administration has issued a warning about possible kidney problems associated with the use of Byetta, a diabetes drug marketed by Amylin Pharmaceuticals Inc. and Eli Lilly & Co.

The FDA received 78 reports of kidney problems in patients using Byetta from April 2005 through October 2008, it said in an announcement published Tuesday.

“Health care professionals and patients taking Byetta should pay close attention to any signs or symptoms of kidney problems,” said Amy Egan of the FDA’s Center for Drug...
To view the full article, register now.